Subcutaneous Electrodes TRIZ Cases

Implanted graphite sheets spread current and heat more evenly, enabling higher TTFields delivery with fewer hot spots and less tissue damage.

Ultrasound-guided percutaneous needle placement resolves the trade-off between minimally invasive access and precise vagus nerve targeting.

A subcutaneous cardioverter-defibrillator uses distributed high-voltage electrodes to deliver therapy without transvenous leads.

Segmented housing with a bellows-like intermediate portion allows precise positioning near neuralgic regions, reducing surgical trauma from long leads.

Flexible anchoring arms secure subcutaneous leads via a single incision, reducing infection risk and visible scarring.

Subcutaneous force sensors transmit wireless signals via magnetic human body communication to a base unit for peripheral nerve stimulation.

A subcutaneous implantable cardioverter defibrillator generates an alarm signal upon detecting arrhythmia to alert the patient before treatment delivery.

Surface electrode placement directs stimulus current to target tissue while minimizing corrosion and shunting.

Neural interfaces implant on target nerves to deliver bioelectronic neuromodulation protocols that influence the tumor microenvironment.

A medical device system uses implanted and external electrodes to deliver therapeutic electric fields at 10 kHz to 1 MHz frequencies.

Disposable biodegradable implants eliminate removal surgery risks by absorbing after treatment, reducing health hazards from permanent devices.